Amgen Analyst Price Targets - Benzinga

Amgen Inc

AMGNNASDAQ

Trade with Public

Trade with Public

$441.46

16.183.8%

마지막 업데이트: Aug 19, 2:32 PM

PRO

변동 이유?:Amgen shares are trading higher after Argus Research raised its price targe...

배당금: 배당락일은 내일입니다

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 주식 보고서

Amgen Analyst Price Targets

Wall Street analyst price targets and consensus rating for Amgen (AMGN).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

8Buy

10Hold

2Sell

Consensus RatingOutperform# Analysts20Avg. Consensus PT$373Upside to Avg. PT-15.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 19, 2026	Argus Research	Jasper Hellweg	PT Raise	Buy	$375→$460
Aug 18, 2026	Mizuho	Salim Syed	PT Raise	Neutral	$303→$352
Aug 18, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Neutral	$350→$400
Aug 14, 2026	Barclays	Emily Field	PT Raise	Equal-Weight	$360→$380
Aug 10, 2026	Guggenheim	Vamil Divan	PT Raise	Neutral	$343→$388
Aug 7, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$345→$405
Aug 6, 2026	Bernstein	Courtney Breen	PT Raise	Market Perform	$335→$345
Aug 5, 2026	UBS	Michael Yee	PT Raise	Buy	$420→$440
Aug 5, 2026	TD Cowen	Yaron Werber	PT Raise	Buy	$420→$452
Aug 5, 2026	Truist Securities	Gregory Renza	PT Raise	Hold	$340→$362
Aug 5, 2026	Oppenheimer	Jay Olson	PT Raise	Outperform	$400→$450
Aug 5, 2026	Scotiabank	Louise Chen	PT Raise	Sector Outperform	$385→$450
Aug 5, 2026	RBC Capital	Luca Issi	PT Raise	Outperform	$370→$400
Aug 5, 2026	Wells Fargo	Mohit Bansal	PT Raise	Equal-Weight	$390→$400
Aug 5, 2026	BMO Capital	Evan David Seigerman	PT Raise	Outperform	$400→$450
Jul 29, 2026	Barclays	Emily Field	PT Raise	Equal-Weight	$350→$360
Jul 13, 2026	UBS	Michael Yee	PT Raise	Buy	$400→$420
Jul 13, 2026	Guggenheim	Vamil Divan	PT Raise	Neutral	$340→$343
Jul 8, 2026	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$340→$333
Jul 7, 2026	Truist Securities	Gregory Renza	PT Raise	Hold	$327→$340

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Argus Research Maintains Buy on Amgen, Raises Price Target to $460

Argus Research analyst Jasper Hellweg maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $375 to $460.

Benzinga Newsdesk

Snowflake To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co raised the price target for argenx SE - ADR (NASDAQ: ARGX) from $940 to $1,202. Goldman Sachs boosted PBF Energy Inc (NYSE: PBF) price target from $71 to $81. B of A Securities increased price target for Americold Realty Trust Inc (NYSE: COLD) from $15 to $16.

Avi Kapoor

PRO
Mizuho Maintains Neutral on Amgen, Raises Price Target to $352

Mizuho analyst Salim Syed maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $303 to $352.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Neutral on Amgen, Raises Price Target to $400

Cantor Fitzgerald analyst Carter Gould maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $350 to $400.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Amgen, Raises Price Target to $380

Barclays analyst Emily Field maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and raises the price target from $360 to $380.

Benzinga Newsdesk

PRO
Guggenheim Maintains Neutral on Amgen, Raises Price Target to $388

Guggenheim analyst Vamil Divan maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $343 to $388.

Benzinga Newsdesk